ID
20229
Description
The purpose of the trial is to determine if extended-release dipyridamole + aspirin [Aggrenox, Asasa ntin] is superior to clopidogrel [Plavix], and if telmisartan [Micardis, Gliosartan, Kinzal, Kinzalm ono, Predxal, Pritor, Samertan, Telmisartan] is superior to placebo, in the presence of background antihypertensive therapy, in prevention of a second stroke in patients who have recently suffered a stroke and therefore are at high risk of suffering another one.
Keywords
Versions (2)
- 2/15/17 2/15/17 -
- 2/20/17 2/20/17 -
Uploaded on
February 15, 2017
DOI
To request one please log in.
License
Creative Commons BY-NC 3.0
Model comments :
You can comment on the data model here. Via the speech bubbles at the itemgroups and items you can add comments to those specificially.
Itemgroup comments for :
Item comments for :
In order to download data models you must be logged in. Please log in or register for free.
Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Visit 1 Month 0 Toast Criteria Concomitant Medication ACE Inhibitors PRoFESS - Prevention Regimen For Effectively Avoiding Second Strokes NCT00153062
Description
Concomitant Medication
Alias
- UMLS CUI-1
- C2347852
Description
Medication taken
Data type
boolean
Description
If the patient is taking any restricted (bolded) concomitant medications (see facing page), please ensure these are stopped prior to randomasation.
Data type
integer
Description
ACE Inhibitors
Alias
- UMLS CUI-1
- C0003015
No comments